$7.01
-0.28(-3.77%)
Mkt Cap $494M
$5.30
$23.11
52-Week Range
At A Glance
1
Breeze Holdings Acquisition Corp.
2
Most recently: Current Report on Form 6-K (2026-02-26).
$494M
Market Cap
—
Revenue
-$62M
Net Income
Employees4
Fundamentals
How The Business Makes Money
Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.
Industry Biotechnology
Activity
What Changed Recently
Company Profile
CIK0002011674
ISINKYG983011076
CUSIPG98301107
AddressNo. 3, Xingnan St., Taipei, 115001, TW
SEC EDGAR